Navigation Links
Study Data Show INTUNIV™ (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD Symptom Improvement in Children and Adolescents
Date:5/21/2010

tudy, no unique adverse events were observed with INTUNIV given with stimulant compared with those reported with either treatment alone.  The most commonly reported treatment emergent adverse events (TEAEs) among patients treated with INTUNIV and a stimulant (greater than or equal to 5 percent) were headache, somnolence, upper respiratory tract infection, fatigue, insomnia, upper abdominal pain, dizziness, decreased appetite, cough, irritability, and nausea.  The most commonly reported TEAEs among patients in the placebo/stimulant group were headache, upper respiratory tract infection, and irritability.  The majority of TEAEs were mild to moderate in severity.   The rate of discontinuation due to TEAEs was 2.7 percent in the INTUNIV AM/stimulant group, 3.9 percent in the INTUNIV PM/stimulant group, and 0.7 percent in the placebo/stimulant group.  There were three serious adverse events reported among study participants (including one report of syncope) and all were considered unrelated to study drug.  No deaths occurred during the study.

"Shire is committed to ADHD and continues to develop a range of ADHD treatments for health care providers and patients," said Michael Yasick, Senior Vice President of Shire's ADHD Business Unit.  "We are pleased with the results of this trial and are currently working with the FDA to secure an indication for use of INTUNIV with stimulants in the treatment of ADHD."  

This study was supported by funding from Shire Development Inc.  Dr Timothy Wilens was a speaker and received grant support from and is a consultant for Shire.  

*Suboptimal response was defined as treatment with a stable dose of stimulant for at least four weeks with improvement, yet persistence of mild to moderate ADHD symptoms (defined as an ADHD-RS-IV total score of at least 24 an
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
2. New Prime Therapeutics Study Finds Antiviral Medications Were Not Hoarded During H1N1 Flu Season
3. New Study Shows ENJUVIA® Significantly Reduced Sleep Time Awakenings Caused by Hot Flashes in Postmenopausal Women
4. ThromboGenics and BioInvent to Receive EUR10 Million Milestone as Partner Roche Begins New Clinical Study with TB-403
5. Whistleblower Lawyers Comment on New England Journal of Medicine Study
6. Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations
7. QRxPharma Successfully Completes Comparative Phase 1 Proof-of-Concept Study for MoxDuo(R) CR Tablet Formulation
8. QRxPharma Releases Additional Pivotal Phase 3 Combination Rule Study Data for MoxDuo(R)IR in Patients with Post-Surgical Pain
9. Spiral Enteroscopy is Three Times Faster than Double-Balloon Enteroscopy in Diagnosing the Small Intestine, New Study Finds
10. SARcode Corporation Announces Phase 2 Study Results of SAR 1118 Topical Ophthalmic Solution for the Treatment of Dry Eye
11. BetterInvesting Magazine Releases Julys Stock to Study and Undervalued Stock Choices for Investors Informational and Educational Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... LOS ANGELES , March 3, 2015 ... that Andrew Gengos , Chief Executive Officer of ... at the 27 th Annual ROTH Conference on ... the Ritz-Carlton Hotel, Laguna Niguel , ... webcast of the ROTH presentation, please log on through ...
(Date:3/3/2015)... YORK , March 3, 2015  Immune Pharmaceuticals ... announced today that Dr. Daniel Teper , Chief ... on Wednesday, March 11, 2015 at 12:30 pm local ... The presentation will be webcast. ... About Immune Pharmaceuticals Inc. ...
(Date:3/2/2015)... Ill. , March 2, 2015 Cure SMA ... California Institute of Biomedical Research (CALIBR). This funding is an ... in 2012, with a $700,000 Cure SMA grant to Dr. ... drug discovery program, "Optimization of Small Molecules that Increase ... Survival motor neuron (SMN) protein is critical to ...
Breaking Medicine Technology:ImmunoCellular Therapeutics to Present at ROTH Conference on March 10th 2Immune Pharmaceuticals To Present At The Roth Conference 2Immune Pharmaceuticals To Present At The Roth Conference 3Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 2Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 3
... 2011 Hospira, Inc. (NYSE: HSP ), a ... that the company will present at the Sanford C. Bernstein ... in New York. The presentation is scheduled to ... 2011.  It will be available to all interested parties through ...
... May 12, 2011 Men and women infected with ... their sexual partners through initiation of oral antiretroviral therapy ... study conducted by the HIV Prevention Trials Network (HPTN), ... HIV through cutting-edge biomedical, behavioral, and structural interventions. ...
Cached Medicine Technology:Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052) 2Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052) 3Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052) 4Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052) 5
(Date:3/3/2015)... March 03, 2015 After the holiday ... lifestyle of fitness and exercise. Community Health Center of ... presenting 6 ways that families in Everett, Marysville, and ... winter months. , CHC says, “While it’s relatively ... and steamed veggies, many families wonder how to keep ...
(Date:3/3/2015)... 2015 The Forbes Living ... great ideas when planning an Eco-vacation. It will review ... friendly approach. The segment will explore the greenest ground ... resort’s sustainability policy, request Earth-friendly choices along the way, ... about how to save electricity while away. More people ...
(Date:3/3/2015)... 03, 2015 Sponsors of Medicare Advantage ... abundance of significant proposed changes to sift through as ... 2016 Call Letter released Feb. 20. The potential pay ... vary considerably with the type and location of the ... and comment on them before CMS issues the final ...
(Date:3/3/2015)... Dr. Stephen Edgerton, a Cosmetic ... achieved Accredited Member Status in the American Academy ... accomplishment after completing a rigorous credentialing process including ... submission of clinical cases for examination. , ... in Connecticut, Charlotte, North Carolina, Caracas, Venezuela and ...
(Date:3/3/2015)... Lake City, UT (PRWEB) March 03, 2015 ... is an innovative, user-friendly website that focuses on ... therapy, therapeutic boarding schools, and addiction treatment for ... Additionally, all residential interventions on the site have ... anxiety, ADHD, autism spectrum disorders, severe learning disabilities, ...
Breaking Medicine News(10 mins):Health News:6 Wintertime Weight Loss Tips for Family Fitness Presented by Community Health Center of Snohomish County in Recent Article 2Health News:Forbes Living Segment on Planning an Eco-Vacation in the Works 2Health News:March 12 Webinar to Analyze Implications of CMS’s ’45-Day Notice’ and 2016 Call Letter for MA and Part D Plans 2Health News:Dr. Edgerton, a Dentist in Wilmington, NC, Achieves Accredited Status in AACD 2Health News:All Kinds of Therapy – New Website for Behavioral Health and Substance Abuse Treatment Launches Today 2
... Get Fit, Get,Right (http://www.getfitgetright.org ), an online ... type 2 diabetes and weight-related conditions,such as blindness, ... Fit, Get Right participants learn to adopt healthier ... they work to improve their,eating and exercise habits ...
... Performed ... Spinal Surgeries, AUSTIN, Texas, ... developing state-of-the-art, minimally invasive,surgical products, announced today at the North American ... use in some of,the most common spinal surgeries. The MD ...
... Conference Call for October 24th, 2007 at 5:00 p.m. ... (Nasdaq:,NUVA), a medical device company focused on developing products ... it,has cancelled the planned investor event scheduled for October ... Texas so that its CEO can return to,corporate headquarters ...
... WASHINGTON -- Cancer therapies save and prolong many lives, ... exact a debilitating toll on patients, mental and emotional ... with during oncology treatment. Cancer care that focuses ... well-being can increase patients, suffering, may compromise their ability ...
... University researchers to help train people to change their ... now been shown to reduce the production of the ... October issue of the American Psychological Associations Journal of ... it was possible to design games to allow people ...
... (Nasdaq: MDRX ),the leading provider of clinical ... improve healthcare, announced today that,it will report its ... September,30, 2007 after the stock market closes on ... Time on the same day, Allscripts management will,host ...
Cached Medicine News:Health News:MultiVu Video Feed: STARLIGHT STARBRIGHT UNVEILS GET FIT, GET RIGHT A PROGRAM TO PREVENT TYPE 2 DIABETES AND WEIGHT-RELATED CONDITIONS IN TEENS 2Health News:ArthroCare Releases New SpineWand(R) for Less Invasive Spinal Surgeries 2Health News:ArthroCare Releases New SpineWand(R) for Less Invasive Spinal Surgeries 3Health News:NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires 2Health News:NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires 3Health News:NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires 4Health News:Cancer care providers need to proactively address patients' psychological and social needs 2Health News:Cancer care providers need to proactively address patients' psychological and social needs 3Health News:Video game shown to cut cortisol 2Health News:Allscripts to Announce Third Quarter 2007 Results on November 8th 2Health News:Allscripts to Announce Third Quarter 2007 Results on November 8th 3
... UltraFix MiniMite Suture Anchor System ... the market that will accept ... surface until deployed eliminates tissue, ... its ultra smooth eyelet hole ...
... The R-F10 simplifies the ... unprecedented degree - all operations ... a press of the Start ... the entire series of steps ...
... imaging have become more acute. The ... radiation exposure to both patient and staff ... and Bi-Plane systems. In keeping with ... in price/value relationship, four bi-plane imaging configurations ...
... HARMONY Cardiology Module incorporates an integrated ... Open Systems Technology mandated by the ... Allowing for easy access to hospital ... HARMONY provides new efficiency with electronic ...
Medicine Products: